Symbol="CBIO"
AssetType="Common Stock"
Name="Catalyst Biosciences Inc"
Description="Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California."
CIK="1124105"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="611 GATEWAY BLVD., SUITE 710, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="22405200"
EBITDA="-17027000"
PERatio="None"
PEGRatio="0.02"
BookValue="-0.746"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.223"
ReturnOnEquityTTM="-1.131"
RevenueTTM="0"
GrossProfitTTM="-64906000"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="16"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.822"
PriceToBookRatio="0.527"
EVToRevenue="4.975"
EVToEBITDA="-0.592"
Beta="1.393"
num_52WeekHigh="1.238"
num_52WeekLow="0.189"
num_50DayMovingAverage="0.375"
num_200DayMovingAverage="0.341"
SharesOutstanding="37974900"
DividendDate="2023-01-12"
ExDividendDate="2023-01-13"
symbol="CBIO"
open="0.60"
high="0.61"
low="0.54"
price="0.59"
volume="961532.00"
latest_trading_day="2023-08-25"
previous_close="0.52"
change="0.07"
change_percent="13.7308%"
aroon_positive_momentum_days="59"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="497284"
Change_recent_avg="0.01"
Delta_recent_avg="0.03"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-1.48"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="1120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_negative_thumbnail_id_2="1166"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="987"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
